The THC Heart-Rate Dose Meta-Regression Did Not Provide an Individual Dose Calculator

The cardiovascular review found a relationship between THC dose and human heart-rate effect across studies. That meta-regression did not establish a precise pulse change for a particular person.

The analysis concerned study-level effects

The review reports dose-dependent tachycardia in its human analysis and discusses oral trials using several THC doses. Meta-regression relates dose conditions to estimated effects across the included comparisons. It does not automatically reconstruct the exposure-response curve of an individual participant.

Route and timing also changed the exposure

The authors identify heterogeneity in administration route, dose and assessment time. A labeled dose does not ensure a matching peak concentration across those conditions. Combining the study results therefore cannot supply a single conversion from milligrams of THC to beats per minute for clinical or forensic use.

Pulse is not an impairment measurement

The association does not establish that a larger pulse increase always means greater cognitive impairment, nor that an unchanged pulse excludes a drug effect. Those conclusions require their own functional evidence. The useful contribution is a group-level physiological dose signal within a limited historical evidence base. An accurate account preserves the analysis level and protocol variation rather than turning the result into a personal dosing or last-use estimate.

Related analysis: the study’s broader findings and limitations.

Research cited

Sultan, Millar, O’Sullivan and England (2018). A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

The CBD Scan Trial Used Equal Allocation Despite Planning a Two-to-One Ratio

The scan-anxiety study ultimately randomized twenty-five participants to each treatment. The paper disclosed that its original sample-size plan anticipated a two-to-one allocation instead. The discrepancy concerned the allocation ratio The central registrar inadvertently implemented a one-to-one scheme rather than the originally intended unequal ratio. Participants still underwent randomized assignment, and…

Spread the love

Read Article: The CBD Scan Trial Used Equal Allocation Despite Planning a Two-to-One Ratio

Only Six Participants Had Severe Baseline Anxiety in the CBD Scan Trial

The scan-anxiety trial stratified randomization by baseline anxiety severity, but only six participants were in its severe category. Stratification did not supply enough data for a reliable severe-anxiety subgroup analysis. The strata helped organize allocation Participants were assigned within GAD-7 categories covering mild-to-moderate and severe anxiety. Of the fifty women…

Spread the love

Read Article: Only Six Participants Had Severe Baseline Anxiety in the CBD Scan Trial

The CBD Scan-Anxiety Trial Measured Prescan Anxiety, Not Anxiety During the Scan

The trial’s acute anxiety assessment occurred after CBD dosing but generally before the scheduled cancer scan. It did not directly measure whether CBD reduced distress inside the scanner. The two timing intervals were different Participants received the study drug within 48 hours before a tumor-assessment scan. Anxiety was reassessed two…

Spread the love

Read Article: The CBD Scan-Anxiety Trial Measured Prescan Anxiety, Not Anxiety During the Scan

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us